Results
|
121.
|
|
|
122.
|
|
|
123.
|
|
|
124.
|
|
|
125.
|
|
|
126.
|
|
|
127.
|
|
|
128.
|
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. [electronic resource] by
- Schnur, R C
- Corman, M L
- Gallaschun, R J
- Cooper, B A
- Dee, M F
- Doty, J L
- Muzzi, M L
- DiOrio, C I
- Barbacci, E G
- Miller, P E
Producer: 19951025
In:
Journal of medicinal chemistry vol. 38
Availability: No items available.
|
|
129.
|
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. [electronic resource] by
- Schnur, R C
- Corman, M L
- Gallaschun, R J
- Cooper, B A
- Dee, M F
- Doty, J L
- Muzzi, M L
- Moyer, J D
- DiOrio, C I
- Barbacci, E G
Producer: 19951025
In:
Journal of medicinal chemistry vol. 38
Availability: No items available.
|
|
130.
|
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. [electronic resource] by
- Baskar, P V
- Collins, G D
- Dorsey-Cooper, B A
- Pyle, R S
- Nagel, J E
- Dwyer, D
- Dunston, G
- Johnson, C E
- Kendig, N
- Israel, E
- Nalin, D R
- Adler, W H
Producer: 19980313
In:
Clinical and experimental immunology vol. 111
Availability: No items available.
|
|
131.
|
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. [electronic resource] by
- Miaskowski, C
- Cooper, B A
- Aouizerat, B
- Melisko, M
- Chen, L-M
- Dunn, L
- Hu, X
- Kober, K M
- Mastick, J
- Levine, J D
- Hammer, M
- Wright, F
- Harris, J
- Armes, J
- Furlong, E
- Fox, P
- Ream, E
- Maguire, R
- Kearney, N
Producer: 20180326
In:
European journal of cancer care vol. 26
Availability: No items available.
|